- Home
- TRST vs XNCR Comparison
TRST vs XNCR Comparison
Compare TRST & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- XNCR
- Stock Information
- Founded
- TRST 1902
- XNCR 1997
- Country
- TRST United States
- XNCR United States
- Employees
- TRST N/A
- XNCR N/A
- Industry
- TRST Major Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- XNCR Health Care
- Exchange
- TRST Nasdaq
- XNCR Nasdaq
- Market Cap
- TRST 669.9M
- XNCR 565.1M
- IPO Year
- TRST N/A
- XNCR 2013
- Fundamental
- Price
- TRST $35.10
- XNCR $8.97
- Analyst Decision
- TRST
- XNCR Buy
- Analyst Count
- TRST 0
- XNCR 7
- Target Price
- TRST N/A
- XNCR $27.50
- AVG Volume (30 Days)
- TRST 94.9K
- XNCR 754.1K
- Earning Date
- TRST 07-21-2025
- XNCR 08-04-2025
- Dividend Yield
- TRST 4.07%
- XNCR N/A
- EPS Growth
- TRST N/A
- XNCR N/A
- EPS
- TRST 2.68
- XNCR N/A
- Revenue
- TRST $173,999,000.00
- XNCR $127,228,000.00
- Revenue This Year
- TRST $13.13
- XNCR N/A
- Revenue Next Year
- TRST N/A
- XNCR $28.84
- P/E Ratio
- TRST $13.19
- XNCR N/A
- Revenue Growth
- TRST N/A
- XNCR N/A
- 52 Week Low
- TRST $27.18
- XNCR $7.16
- 52 Week High
- TRST $38.89
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- TRST 66.05
- XNCR 53.51
- Support Level
- TRST $33.89
- XNCR $8.36
- Resistance Level
- TRST $35.53
- XNCR $9.02
- Average True Range (ATR)
- TRST 0.76
- XNCR 0.51
- MACD
- TRST -0.01
- XNCR 0.08
- Stochastic Oscillator
- TRST 90.12
- XNCR 72.33
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.